BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8145003)

  • 1. Differential effects of ferritin, calcium, zinc, and gallic acid on in vitro proliferation of human glioblastoma cells and normal astrocytes.
    Beljanski M; Crochet S
    J Lab Clin Med; 1994 Apr; 123(4):547-55. PubMed ID: 8145003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PB-100: a potent and selective inhibitor of human BCNU resistant glioblastoma cell multiplication.
    Beljanski M; Crochet S; Beljanski MS
    Anticancer Res; 1993; 13(6A):2301-8. PubMed ID: 8297150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cellular pathways involved in glioblastoma response to the chemotherapeutic agent 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profiling.
    Rhee CH; Ruan S; Chen S; Chenchik A; Levin VA; Yung AW; Fuller GN; Zhang W
    Oncol Rep; 1999; 6(2):393-401. PubMed ID: 10023010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher glioblastoma tumour burden reduces efficacy of chemotherapeutic agents: in vitro evidence.
    Ng WH; Wan GQ; Too HP
    J Clin Neurosci; 2007 Mar; 14(3):261-6. PubMed ID: 17258135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Methoxyestradiol inhibits proliferation of normal and neoplastic glial cells, and induces cell death, in vitro.
    Lis A; Ciesielski MJ; Barone TA; Scott BE; Fenstermaker RA; Plunkett RJ
    Cancer Lett; 2004 Sep; 213(1):57-65. PubMed ID: 15312684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.
    Batista LF; Roos WP; Christmann M; Menck CF; Kaina B
    Cancer Res; 2007 Dec; 67(24):11886-95. PubMed ID: 18089819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Growth inhibition of epidermal growth factor-stimulated human glioblastoma cells by nicardipine in vito].
    Huang CX; Chen B; Zhang YF
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):211-4. PubMed ID: 12536683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells.
    Rahaman SO; Harbor PC; Chernova O; Barnett GH; Vogelbaum MA; Haque SJ
    Oncogene; 2002 Dec; 21(55):8404-13. PubMed ID: 12466961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactive properties of human glioblastoma cells with brain neurons in culture and neuronal modulation of glial laminin organization.
    Faria J; Romão L; Martins S; Alves T; Mendes FA; de Faria GP; Hollanda R; Takiya C; Chimelli L; Morandi V; de Souza JM; Abreu JG; Moura Neto V
    Differentiation; 2006 Dec; 74(9-10):562-72. PubMed ID: 17177853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4.
    Brockmann MA; Papadimitriou A; Brandt M; Fillbrandt R; Westphal M; Lamszus K
    Clin Cancer Res; 2003 Oct; 9(12):4578-85. PubMed ID: 14555533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of gap junctional communication between tumor cells and astroglia to the invasion of the brain parenchyma by human glioblastomas.
    Oliveira R; Christov C; Guillamo JS; de Boüard S; Palfi S; Venance L; Tardy M; Peschanski M
    BMC Cell Biol; 2005 Feb; 6(1):7. PubMed ID: 15715906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between DNA damage and growth inhibition induced by topoisomerase II-interfering drugs in doxorubicin-sensitive and -resistant rat glioblastoma cells.
    de Tinguy-Moreaud E; Pourquier P; Montaudon D; Robert J
    Anticancer Res; 1994; 14(1A):99-103. PubMed ID: 8166463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From rodent glial precursor cell to human glial neoplasia in the oligodendrocyte-type-2 astrocyte lineage.
    Noble M; Gutowski N; Bevan K; Engel U; Linskey M; Urenjak J; Bhakoo K; Williams S
    Glia; 1995 Nov; 15(3):222-30. PubMed ID: 8586459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of mortalin expression in human brain tumors.
    Takano S; Wadhwa R; Yoshii Y; Nose T; Kaul SC; Mitsui Y
    Exp Cell Res; 1997 Nov; 237(1):38-45. PubMed ID: 9417864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor.
    Deshayes F; Laprée G; Portier A; Richard Y; Pencalet P; Mahieu-Caputo D; Horellou P; Tsapis A
    Oncogene; 2004 Apr; 23(17):3005-12. PubMed ID: 14691452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of cell death by ascorbic acid derivatives in human renal carcinoma and glioblastoma cell lines.
    Makino Y; Sakagami H; Takeda M
    Anticancer Res; 1999; 19(4B):3125-32. PubMed ID: 10652601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense human neuroglia related cell adhesion molecule hNr-CAM, reduces the tumorigenic properties of human glioblastoma cells.
    Sehgal A; Ricks S; Warrick J; Boynton AL; Murphy GP
    Anticancer Res; 1999; 19(6B):4947-53. PubMed ID: 10697494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of DNA damage in transcriptionally active genes by RT-PCR and assessment of repair of cisplatin-induced damage in the glutathione S-transferase-pi gene in human glioblastoma cells.
    Brandt TY; Ali-Osman F
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):22-9. PubMed ID: 9073588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin.
    Ruan S; Okcu MF; Ren JP; Chiao P; Andreeff M; Levin V; Zhang W
    Cancer Res; 1998 Apr; 58(7):1538-43. PubMed ID: 9537261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioblastoma cell lines differing in p53 status.
    Zhao S; Tsuchida T; Kawakami K; Shi C; Kawamoto K
    Int J Oncol; 2002 Jul; 21(1):49-55. PubMed ID: 12063549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.